Rectal cancer
NanoEcho AB (publ) is engaged in clinical research centered on rectal cancer, with an emphasis on imaging of rectal lymph nodes to support evaluation in both healthy volunteers and patients with disease. The work is closely tied to oncology and the assessment of regional nodal involvement.
- Rectal lymph node imaging
- Oncologic assessment
- Healthy volunteer evaluation
The sponsor’s current research activity in Sweden reflects interest in gastrointestinal cancer diagnostics and the clinical use of imaging tools for examining pelvic lymphatic structures.
Medical imaging
The sponsor’s trial portfolio includes the use of a dedicated imaging device for examining rectal lymph nodes, highlighting a focus on diagnostic visualization in clinical oncology. This area connects device-based imaging with disease evaluation in both non-cancer and cancer settings.
- Imaging device evaluation
- Diagnostic visualization
- Lymph node examination
The research activity is directed toward refining how medical imaging can be applied to detect and assess nodal anatomy relevant to rectal malignancy.
Healthy volunteer studies
NanoEcho AB (publ) also funds research involving healthy volunteers to examine the performance of its imaging approach in intact rectal lymph nodes. This supports the clinical characterization of the method before use in patients with rectal cancer.
- Volunteer-based imaging assessment
- Safety evaluation
- Physiologic lymph node imaging
This area links early clinical evaluation with the practical study of anatomical imaging in individuals without cancer.
Contrast agent and particle-based diagnostics
The sponsor’s research includes the clinical investigation of ferumoxtran and related nano-particle imaging applications for lymph node examination. The therapeutic and diagnostic interest lies in improving visualization of lymphatic tissue associated with rectal cancer.
- Ferumoxtran-based imaging
- Nanoparticle diagnostics
- Lymphatic tissue assessment
This research domain combines molecular imaging concepts with clinical evaluation of nodal structures relevant to cancer staging and assessment.
